Report Detail
Global Cardiac Resynchronization Therapy (CRT) Devices Market Insights, Forecast to 2025
- RnM3480361 |
- 31 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy diet. CRT device is an implantable medical device that are used to resynchronize the contractions of the heart’s ventricles by sending tiny electrical impulses to the heart muscle, to pump the blood more efficiently.
One of the various factors that back the market growth of cardiac resynchronization therapy devices market is the expanding pool of aging and geriatric patients worldwide. That segment of the human population is more vulnerable to chronic illness and is, as such, expected to generate the immense need for these resynchronization therapy gadgets so as to facilitate and accelerate sound heart activity. Other than cardiac arrest, there are some other medical conditions like atrial fibrillation, congenital heart disease, and arrhythmias which also require the implementation and usage of these cardiac resynchronization therapy devices.
Growing prevalence of various cardiovascular diseases like cardiac arrest, sick sinus syndrome, and bradycardia are also bolstering the growth of market. To diminish the rate of mortality arising out of cardiovascular illness, many hospitals have already initiated the use of CRT-Ps for managing the failures of heart. Furthermore, many doctors are increasing the usage of surgeries that are minimally invasive (MI) for various CRT-Ps implantation. These procedures are considered safe, diminish the blood transfusion requirement. It also decreases chances of infections and reduces stay at the hospital. This eventually accelerates the recovering and process thereby leading to much improved clinical outcome. This change in inclination towards minimally invasive procedures for the purpose of CRT-Ps implantation is poised to trigger the sales of the cardiac resynchronization therapy devices in the years to come.
The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing growth of geriatric population suffering from cardiac dysfunction. As of 2016, it held more 36.0% of the global market share. Europe also held a substantial share and is predicted to witness lucrative growth with CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth.
The global Cardiac Resynchronization Therapy (CRT) Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Resynchronization Therapy (CRT) Devices market based on company, product type, end user and key regions.
This report studies the global market size of Cardiac Resynchronization Therapy (CRT) Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Resynchronization Therapy (CRT) Devices in these regions.
This research report categorizes the global Cardiac Resynchronization Therapy (CRT) Devices market by top players/brands, region, type and end user. This report also studies the global Cardiac Resynchronization Therapy (CRT) Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
St. Jude Medical
Biotronik
Cook Medical
Sorin Group
Market size by Product
CRT-Pacemakers
CRT-Defibrillators
Market size by End User
Healthcare Industry
Cardiovascular industry
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cardiac Resynchronization Therapy (CRT) Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Resynchronization Therapy (CRT) Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Resynchronization Therapy (CRT) Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Resynchronization Therapy (CRT) Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cardiac Resynchronization Therapy (CRT) Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Resynchronization Therapy (CRT) Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cardiac Resynchronization Therapy (CRT) Devices Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Growth Rate by Product
- 1.4.2 CRT-Pacemakers
- 1.4.3 CRT-Defibrillators
- 1.5 Market by End User
- 1.5.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Growth Rate by End User
- 1.5.2 Healthcare Industry
- 1.5.3 Cardiovascular industry
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Market Size
- 2.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue 2014-2025
- 2.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Sales 2014-2025
- 2.2 Cardiac Resynchronization Therapy (CRT) Devices Growth Rate by Regions
- 2.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Sales by Regions
- 2.2.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cardiac Resynchronization Therapy (CRT) Devices Sales by Manufacturers
- 3.1.1 Cardiac Resynchronization Therapy (CRT) Devices Sales by Manufacturers
- 3.1.2 Cardiac Resynchronization Therapy (CRT) Devices Sales Market Share by Manufacturers
- 3.1.3 Global Cardiac Resynchronization Therapy (CRT) Devices Market Concentration Ratio (CR5 and HHI)
- 3.2 Cardiac Resynchronization Therapy (CRT) Devices Revenue by Manufacturers
- 3.2.1 Cardiac Resynchronization Therapy (CRT) Devices Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiac Resynchronization Therapy (CRT) Devices Revenue Share by Manufacturers (2014-2019)
- 3.3 Cardiac Resynchronization Therapy (CRT) Devices Price by Manufacturers
- 3.4 Cardiac Resynchronization Therapy (CRT) Devices Manufacturing Base Distribution, Product Types
- 3.4.1 Cardiac Resynchronization Therapy (CRT) Devices Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cardiac Resynchronization Therapy (CRT) Devices Product Type
- 3.4.3 Date of International Manufacturers Enter into Cardiac Resynchronization Therapy (CRT) Devices Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cardiac Resynchronization Therapy (CRT) Devices Sales by Product
- 4.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue by Product
- 4.3 Cardiac Resynchronization Therapy (CRT) Devices Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cardiac Resynchronization Therapy (CRT) Devices Breakdown Data by End User
6 North America
- 6.1 North America Cardiac Resynchronization Therapy (CRT) Devices by Countries
- 6.1.1 North America Cardiac Resynchronization Therapy (CRT) Devices Sales by Countries
- 6.1.2 North America Cardiac Resynchronization Therapy (CRT) Devices Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cardiac Resynchronization Therapy (CRT) Devices by Product
- 6.3 North America Cardiac Resynchronization Therapy (CRT) Devices by End User
7 Europe
- 7.1 Europe Cardiac Resynchronization Therapy (CRT) Devices by Countries
- 7.1.1 Europe Cardiac Resynchronization Therapy (CRT) Devices Sales by Countries
- 7.1.2 Europe Cardiac Resynchronization Therapy (CRT) Devices Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cardiac Resynchronization Therapy (CRT) Devices by Product
- 7.3 Europe Cardiac Resynchronization Therapy (CRT) Devices by End User
8 Asia Pacific
- 8.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices by Countries
- 8.1.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Sales by Countries
- 8.1.2 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices by Product
- 8.3 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices by End User
9 Central & South America
- 9.1 Central & South America Cardiac Resynchronization Therapy (CRT) Devices by Countries
- 9.1.1 Central & South America Cardiac Resynchronization Therapy (CRT) Devices Sales by Countries
- 9.1.2 Central & South America Cardiac Resynchronization Therapy (CRT) Devices Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cardiac Resynchronization Therapy (CRT) Devices by Product
- 9.3 Central & South America Cardiac Resynchronization Therapy (CRT) Devices by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices by Countries
- 10.1.1 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices Sales by Countries
- 10.1.2 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices by Product
- 10.3 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices by End User
11 Company Profiles
- 11.1 Boston Scientific
- 11.1.1 Boston Scientific Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Boston Scientific Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Boston Scientific Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.1.5 Boston Scientific Recent Development
- 11.2 Medtronic
- 11.2.1 Medtronic Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Medtronic Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Medtronic Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.2.5 Medtronic Recent Development
- 11.3 St. Jude Medical
- 11.3.1 St. Jude Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 St. Jude Medical Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 St. Jude Medical Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.3.5 St. Jude Medical Recent Development
- 11.4 Biotronik
- 11.4.1 Biotronik Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Biotronik Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Biotronik Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.4.5 Biotronik Recent Development
- 11.5 Cook Medical
- 11.5.1 Cook Medical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cook Medical Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cook Medical Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.5.5 Cook Medical Recent Development
- 11.6 Sorin Group
- 11.6.1 Sorin Group Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sorin Group Cardiac Resynchronization Therapy (CRT) Devices Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sorin Group Cardiac Resynchronization Therapy (CRT) Devices Products Offered
- 11.6.5 Sorin Group Recent Development
12 Future Forecast
- 12.1 Cardiac Resynchronization Therapy (CRT) Devices Market Forecast by Regions
- 12.1.1 Global Cardiac Resynchronization Therapy (CRT) Devices Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue Forecast by Regions 2019-2025
- 12.2 Cardiac Resynchronization Therapy (CRT) Devices Market Forecast by Product
- 12.2.1 Global Cardiac Resynchronization Therapy (CRT) Devices Sales Forecast by Product 2019-2025
- 12.2.2 Global Cardiac Resynchronization Therapy (CRT) Devices Revenue Forecast by Product 2019-2025
- 12.3 Cardiac Resynchronization Therapy (CRT) Devices Market Forecast by End User
- 12.4 North America Cardiac Resynchronization Therapy (CRT) Devices Forecast
- 12.5 Europe Cardiac Resynchronization Therapy (CRT) Devices Forecast
- 12.6 Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Forecast
- 12.7 Central & South America Cardiac Resynchronization Therapy (CRT) Devices Forecast
- 12.8 Middle East and Africa Cardiac Resynchronization Therapy (CRT) Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cardiac Resynchronization Therapy (CRT) Devices Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cardiac Resynchronization Therapy (CRT) Devices . Industry analysis & Market Report on Cardiac Resynchronization Therapy (CRT) Devices is a syndicated market report, published as Global Cardiac Resynchronization Therapy (CRT) Devices Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiac Resynchronization Therapy (CRT) Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
